938 related articles for article (PubMed ID: 20135343)
1. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
2. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
3. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis.
Zintzaras E
Clin Genet; 2006 Apr; 69(4):327-36. PubMed ID: 16630166
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis.
Dong X; Wu J; Liang P; Li J; Yuan L; Liu X
Arch Med Res; 2010 Feb; 41(2):125-33. PubMed ID: 20470942
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
6. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
[TBL] [Abstract][Full Text] [Related]
7. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies.
Zintzaras E
Psychiatr Genet; 2006 Jun; 16(3):105-15. PubMed ID: 16691128
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
Ren A; Wang J
Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
[TBL] [Abstract][Full Text] [Related]
9. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
Yao L; Fang F; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
Wu YL; Ding XX; Sun YH; Yang HY; Sun L
J Neurol Sci; 2013 Dec; 335(1-2):14-21. PubMed ID: 24064257
[TBL] [Abstract][Full Text] [Related]
11. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
12. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
Boccia S; Hung R; Ricciardi G; Gianfagna F; Ebert MP; Fang JY; Gao CM; Götze T; Graziano F; Lacasaña-Navarro M; Lin D; López-Carrillo L; Qiao YL; Shen H; Stolzenberg-Solomon R; Takezaki T; Weng YR; Zhang FF; van Duijn CM; Boffetta P; Taioli E
Am J Epidemiol; 2008 Mar; 167(5):505-16. PubMed ID: 18162478
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
14. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.
Lewis SJ; Harbord RM; Harris R; Smith GD
J Natl Cancer Inst; 2006 Nov; 98(22):1607-22. PubMed ID: 17105984
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
[TBL] [Abstract][Full Text] [Related]
17. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.
Pereira TV; Rudnicki M; Pereira AC; Pombo-de-Oliveira MS; Franco RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1956-63. PubMed ID: 17035405
[TBL] [Abstract][Full Text] [Related]
18. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
Gilbody S; Lewis S; Lightfoot T
Am J Epidemiol; 2007 Jan; 165(1):1-13. PubMed ID: 17074966
[TBL] [Abstract][Full Text] [Related]
20. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Xue K; Zhang J; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
